0001104659-24-011254.txt : 20240206
0001104659-24-011254.hdr.sgml : 20240206
20240206213045
ACCESSION NUMBER: 0001104659-24-011254
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Faulkner Robert C.
CENTRAL INDEX KEY: 0001831991
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36533
FILM NUMBER: 24601913
MAIL ADDRESS:
STREET 1: C/O REDMILE GROUP
STREET 2: ONE LETTERMAN DRIVE, BUILDING D, SUITE D
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MedAvail Holdings, Inc.
CENTRAL INDEX KEY: 0001402479
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 900772394
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4720 E COTTON GIN LOOP
STREET 2: SUITE 220
CITY: PHOENIX
STATE: AZ
ZIP: 85040
BUSINESS PHONE: 1.877.830.0826
MAIL ADDRESS:
STREET 1: 4720 E COTTON GIN LOOP
STREET 2: SUITE 220
CITY: PHOENIX
STATE: AZ
ZIP: 85040
FORMER COMPANY:
FORMER CONFORMED NAME: MYOS RENS TECHNOLOGY INC.
DATE OF NAME CHANGE: 20160322
FORMER COMPANY:
FORMER CONFORMED NAME: MYOS Corp
DATE OF NAME CHANGE: 20120521
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Therapeutics Corp
DATE OF NAME CHANGE: 20100719
4
1
tm245380-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-02
1
0001402479
MedAvail Holdings, Inc.
MDVL
0001831991
Faulkner Robert C.
C/O REDMILE GROUP, LLC ONE LETTERMAN
DRIVE, BUILDING D SUITE D3-300
SAN FRANCISCO
CA
94129
1
0
0
0
0
Rob Faulkner, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. Effective as of February 2, 2024, Mr. Faulkner resigned from his position as a member of the Issuer's board of directors prior to the Issuer's filing of a voluntary petition for relief under the provisions of Chapter 7 of Title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware. As a result of Mr. Faulkner's resignation, Redmile and Mr. Green have also ceased to be directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
/s/ Robert C. Faulkner
2024-02-06